Gemoscan reports strong financial results for the second quarter 2014

Toronto, 29. November 2013. Gemoscan Canada Inc.. (TSX-V: GES; MUN: 1GE) ("Gemoscan" or the "Company"), a leading owner and marketer of food intolerance- and diet management solutions, today announced the operation- and financial results for the six months and the second fiscal quarter, on 30. September 2013 have come to an end. In this press release, all amounts are in Canadian currency given, and the results are in accordance with International Financial Reporting Standards („IFRS“) reported.

Thanks to the emphasis of the company in the distribution to consumers in the emerging retail health industry, including traditional pharmacies and paramedical clinics, the company achieved better results than expected. The company's programs are in Canada in almost 600 Pharmacies and paramedical clinics available.

The latest financial results reflect the recently reported by the company acquiring Physiomed Kennedy Inc. (the "clinic"), a wide range of para medical clinic, resist and reaffirm the financial results of the hospital from August and September 2013.

In the six months, on 30. September 2013 have come to an end, sales amounted to 1.041.196 $ - An increase of 95 Percent compared to the same period of fiscal 2012 (533.370 $). Revenues for the second quarter amounted to yourself 667.302 $ - An increase of 138 % compared to the same quarter of fiscal 2012 (280.629 $).

For the six months, on 30. September 2013 have come to an end, the company reported net loss and a lower than expected (622.128 $); in the same period of fiscal year 2012 were it 1.109.214 $ been. For the second fiscal quarter, a lower net loss has been reported as expected (386.681 $); in the same period of fiscal year 2012 were it 571.663 $ been.

The company reported for the six months, on 30. September 2013 have come to an end, also a significant reduction in the time spent on the operational activities on capital 217.395 $; in the same period of fiscal year 2012 were it 576.056 $ been.

All financial statements and Management's Discussion and Analysis are available at www.sedar.com.

Über Gemoscan Canada Inc..

Gemoscan is an industry leader in food intolerance management and has the face of a sales across Canada through selected retail partners held a first-class market position. Gemoscan, the year 2003 was founded, developed, owns and markets using its own patented technology, holistic food intolerance- and diet management solutions for consumers, including the HEMOCODETM ™ Food Intolerance System und des MenuWise™ Food Intolerance Plan, Gemoscan the first and only provider to commercialize a food intolerance management solution for consumers in partnership with retailers and today offers the ganzheitlichsten Service, which is available on the market. Gemoscan owns and operates Physiomed Kennedy Inc., a versatile para medical clinic in Toronto (Ontario).

The shares of Gemoscan be on the Toronto Venture Stock Exchange under the symbol "TOT" and on the Munich Stock Exchange, Frankfurt and Stuttgart traded under the symbol "1GE".

Forward-Looking Information

This press release contains certain "forward-looking information". All statements, that are not historical facts and that address activities, Related events or developments, the Gemoscan believes, expected or suspected, or may occur in the future. These forward-looking statements reflect the current expectations or beliefs of Gemoscan resist, based on the information currently available. Forward-looking statements involve a number of significant risks and uncertainties or other factors, which could cause, that the company's actual results to differ materially from those, projected in forward-looking statements. And even if such actual results are realized or substantially realized, there is no guarantee, be that they have the expected consequences to, or effects on Gemoscan. Forward-looking statements speak only as of the date, on which it is made, and Gemoscan is not required - unless required by law - to update any forward-looking statements, whether as a result of new information, future events or results or otherwise. Although Gemoscan considers, that the assumptions regarding forward-looking statements are reasonable, constitute forward-looking statements are not guarantees of future performance. Due to the corresponding uncertainties, you should not rely on such statements.

The TSX Venture Exchange nor its Regulation Services Provider (described in the policies of the TSX Venture Exchange Regulation Services Provider) assume no responsibility for the adequacy or accuracy of this release.

For more information, contact:

Brian Kalish
Chief Executive Officer
Gemoscan Canada, Inc.

+1 (416) 650-1200
E-Mail: bkalish@hemocode.com
Company website: www.gemoscan.com

For the correctness of the translation is any liability assumed! Please note original English message!

Which filings can be found at:
http://www.irw-press.at/press_html.aspx?messageID=29420

 

Those: IRW-Press.com.

This entry was posted in News, News of the corporations, the rare earth metals and and tagged , . Bookmark the permalink.

Comments are closed.